Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

123 results about "Hypersensitivity reaction" patented technology

Hypersensitivity (also called hypersensitivity reaction or intolerance) refers to undesirable reactions produced by the normal immune system, including allergies and autoimmunity. They are usually referred to as an over-reaction of the immune system and these reactions may be damaging, uncomfortable, or occasionally fatal.

Marker and system for diagnosing abdominal sepsis of children and application

The invention discloses a marker and system for diagnosing abdominal sepsis of children and application, and relates to the technical field of disease medical artificial intelligence. According to the technical scheme, the marker for diagnosing the abdominal sepsis of the children is characterized by comprising a hypersensitive C-reactive protein, a neutrophil absolute value, a body weight, a body temperature, a plasma D-dimer, a lymphocyte absolute value, prealbumin, an average platelet volume, asparaginic acid aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, total bile acid and calcium; the system for diagnosing the abdominal sepsis of children comprises a data input module, a database storage module, a disease prediction module and a model efficiency evaluation module. The marker capable of being used for diagnosing the abdominal sepsis of children is obtained on the basis of laboratory inspection indexes, whether a subject suffers from the abdominal sepsis or not can be accurately diagnosed on the basis of machine learning, clinical doctors can be assisted in diagnosis and early intervention, and huge clinical value is achieved.
Owner:ZHEJIANG UNIV

Allergen-binding antibodies useful for treatment of tree pollen allergy

PendingCN121241065AAntibody ingredientsImmunoglobulins against plantsAlderThroat irritation
Tree pollen allergy is seasonal allergy caused by various tree pollen spread in air. The allergy affects a substantial proportion of populations, is particularly significant in European and North America areas, and is characterized by symptoms such as sneezing, nasal obstruction, rhinorrhea, eye itching and lacrimation, and throat irritation. The symptoms typically occur in spring, at which birch, alder, hazel and oak release pollen into the air. Tree pollen allergy is a type 1 hypersensitivity reaction mediated by an immunoglobulin E (IgE) antibody. The present invention relates to antibodies and antigen binding fragments thereof that bind to one or more of tree pollen allergens Bet v 1, Aln g 1, Cor a 1 and Quue a 1, resulting in inhibition of IgE-mediated anaphylaxis.
Owner:ALK ABELLO AS

Pharmaceutical compounds and methods of use

PendingCN119770499ABiocideAntipyreticAllergic dermatitisPharmaceutical Substances
The present invention relates to a pharmaceutical composition for topical use comprising a corticosteroid and an insecticide selected from pyrethrins or synthetic pyrethroid-based insecticides. Also described are methods of using the compositions of the invention for the treatment of allergic dermatitis, in particular insect bite hypersensitivity, in an animal.
Owner:DERMCARE VET PTY LTD

A VHH chain of an anti-APP nanobody and its application

The present invention discloses a VHH chain of an anti-APP nanobody and its application. The anti-APP nanobody of the present invention has the following beneficial effects: (1) small molecule and drug delivery. (2) easy to manufacture and express. (3) high affinity and strong specificity. (4) stable performance and good plasticity. (5) low immunogenicity and good metabolic characteristics. The APP nanobody of the present invention retains the ability of the VVH chain antibody and avoids the introduction of non-human exogenous proteins as much as possible, taking into account the function of effectively binding to anti-APP and the lowest possible heterology. In addition, the reduction of heterology can not only reduce hypersensitivity reactions but also prolong its half-life in the body and improve metabolic characteristics.
Owner:SHENZHEN KANGTI BIOMEDICAL TECH CO LTD

Allergen-binding antibodies suitable for treating tree pollen allergies

PendingJP2026513548AFungiBacteriaAlderAllergic response
Tree pollen allergy is a seasonal allergy caused by various tree pollens suspended in the air. This allergy affects a significant proportion of the population, particularly in Europe and North America, and is characterized by symptoms such as sneezing, nasal congestion, runny nose, itchy or watery eyes, and throat inflammation. These symptoms typically occur in spring when trees such as birch, alder, hazel, and oak release pollen into the air. Tree pollen allergy is a type 1 hypersensitivity reaction mediated by immunoglobulin E (IgE) antibodies. This invention relates to antibodies and their antigen-binding fragments that bind to one or more tree pollen allergens, Bet v 1, Aln g 1, Cor a 1, and Que a 1, and inhibit the IgE-mediated allergic reaction.
Owner:ALK ABELLO AS

Immunologically active fragments of toxoplasma gondii

ActiveUS12156906B2Protozoa antigen ingredientsImmunoglobulinsGondii toxoplasmaExcretory secretory antigens
T. gondii proteins MIC1 and MIC4 are components of excretory / secretory antigens (ESA) that elicit delayed type hypersensitivity (DTH) responses in infected animals. These antigens are capable of inducing IFN-g secretion by splenic T cells (ELISPOT assay), stimulating T cells to produce cytokines that recruit inflammatory monocytes and neutrophils resulting in a positive luminol test (luminol ear assay), and eliciting a positive skin test in the guinea pig.
Owner:WASHINGTON UNIV IN SAINT LOUIS

Composition and kit for preventing or treating autism spectrum disorder and use thereof

In some embodiments, a composition comprising Bifidobacterium bifidum, Bifidobacterium longum, Lactobacillus plantarum, and Streptococcus thermophilus is provided. In some embodiments, provided is the use of a composition of any of the examples herein for preventing or alleviating anxiety and / or sensory hypersensitivity, preventing or treating autism spectrum disorder (ASD), anxiety disorder and / or gastrointestinal (GI) disorder or condition, enhancing attention and / or concentration, or stimulating a GABA receptor in a subject. In some embodiments, methods and kits are provided for preventing or alleviating anxiety and / or sensory hypersensitivity, preventing or treating autism spectrum disorders, anxiety disorders, and / or gastrointestinal disorders or conditions, enhancing attention and / or concentration, or stimulating GABA receptors in a subject. In certain embodiments, the compositions are safe to use and effective to prevent or alleviate anxiety and / or sensory hypersensitivity in subjects, particularly children subjects.
Owner:MICROBIOTA I CENT MAGIC LTD

Postbiotic-based composition for use in the treatment of skin diseases

The present invention refers to a composition including fermented supernatant of Lactobacillus casei or paracasei species. The species is characterized by having in its DNA genome at least one DNA sequence essentially identical to one of the sequences selected from the group consisting of: SEQ ID NO: 1 to 5, and proper diluents and / or carriers and / or excipients. The composition can be used in the treatment and / or prevention of skin and / or dermatological diseases related to inflammation, allergic reactions, contact hypersensitivity reactions and intolerance, excessive sebaceous secretion, exfoliation or microbial dysbiosis, preferably of the epidermis.
Owner:POSTBIOTICA SRL

Construction of immunoreceptor-single-chain antibody fusion protein, and use thereof in control of PVY and tobrfv

The present invention belongs to the technical field of biological control of viral diseases. Disclosed are an immunoreceptor-single-chain antibody fusion protein, and the use thereof in the control of potato virus Y (PVY) and tomato brown rugose fruit virus (ToBRFV). In the present invention, modified immunoreceptor Sr35(Sr35 △27) is fused to single-chain antibody scFvM1 or scFv16 to prepare an immunoreceptor-single-chain antibody fusion protein, which can specifically recognize the coat protein (CP) of PVY or the CP of ToBRFV, activate host resistance, and generate a hypersensitive response (HR). When expressed in plants, the fusion protein can inhibit the infection of PVY or ToBRFV, and has a significant control effect on PVY or ToBRFV.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Administration of vaccines to sites of temporally induced cell-mediated hypersensitivity reactions, to facilitate the development of protective sensitization against infectious diseases and cancers

PendingUS20260174844A1Allergen ingredientsVaccinationHypersensitivity response
Provided are methods of biasing a response of a vaccine recipient's immune system toward protective sensitization. Methods include administering an agent or substance to the site of a subject of a temporally interacting cell-mediated allergic reaction to enhance the resulting level of protective sensitization.
Owner:COIFMAN ROBERT E +1

Acute exacerbation dystrophy risk prediction model for patients with senile chronic obstructive pulmonary disease and construction method thereof

The invention belongs to the field of nursing science, and particularly relates to an acute exacerbation malnutrition risk prediction model for an old chronic obstructive pulmonary disease patient and a construction method of the acute exacerbation malnutrition risk prediction model, which are used for establishing a rapid and accurate prediction model for acute exacerbation malnutrition risk screening and evaluation of the old chronic obstructive pulmonary disease patient. The invention discloses a model for predicting the risk of acute exacerbation dystrophy of an old chronic obstructive pulmonary disease patient. The risk prediction model is a multivariate Logistic regression model: P =-12.845 + 1.022 * age + 0.339 * ethnic + 0.077 * educated degree + 0.683 * gastrointestinal tract symptom + 0.035 * height-0.126 * body mass index + 1.045 * partial pressure of carbon dioxide-0.077 * chloride ion-0.017 * serum albumin-0.004 * prealbumin + 0.005 * hypersensitive C reaction protein + 0.479 * lymphocyte number. According to the acute exacerbation malnutrition risk prediction model for the patient with the chronic obstructive pulmonary disease of the aged and the construction method thereof, the prediction model for rapidly and accurately screening and evaluating the acute exacerbation malnutrition risk of the patient with the chronic obstructive pulmonary disease of the aged is established.
Owner:THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF SCI & TECH

Pediococcus acidilactici with functions of improving emotion and intestinal health and application of pediococcus acidilactici

The invention provides pediococcus acidilactici with functions of improving emotion and intestinal health and application of the pediococcus acidilactici. The pediococcus acidilactici A25-4 is preserved in Guangdong Microbial Culture Collection Center on May 23, 2025, and the preservation number of the pediococcus acidilactici A25-4 is GDMCC NO: 66384. The pediococcus acidilactici A25-4 has better cholate resistance and artificial gastrointestinal fluid resistance and can produce indole lactic acid ILA at high yield, and the optimal carbon source is fructo-oligosaccharide and galactooligosaccharide. The pediococcus acidilactici A25-4 in-vivo intervention can significantly improve the symptoms of an irritable bowel syndrome model mouse, specifically, the anxiety mood of a tested object is significantly improved; the viscera hypersensitivity of a tested object is obviously relieved; excessive activation of mast cells of a tested object is obviously inhibited; the ILA level in a tested object is obviously improved.
Owner:深圳市轩龙精准营养科技有限公司

Marker for diagnosing or identifying potential cause of migraine, application, kit, device and evaluation model

The invention belongs to the field of marker detection, and particularly relates to a marker for diagnosing or identifying potential causes of migraine, application, a kit, a device and an evaluation model. The invention provides a marker for diagnosing or identifying potential causes of migraine. The marker comprises indoleacrylic acid and / or hypersensitive C-reactive protein. The invention reveals that PFO is combined with migraine metabonomics maps, and branched chain amino acid metabolism, neurosteroid metabolism and tryptophan metabolism disorder are core pathological mechanisms for the first time. On the basis of plasma metabonomics characteristics of a PFO-combined migraine patient and a healthy control, 211 metabolites with significant difference are screened out, it is found that various metabolites are significantly related to the symptom severity of migraine, and two factors [indoleacrylic acid and hypersensitive C-reactive protein (hs-CRP)] significantly related to migraine related to patent foramen ovale are confirmed. In addition, the concentration of indolecrylic acid (IA) is found to have a relatively good prediction value on symptom relief after occlusion.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL

Method for detecting allergen in drug-induced allergic shock

The invention belongs to the field of forensic detection, and particularly relates to a method for detecting allergens in drug-induced allergic shock. Based on a type I hypersensitivity reaction mechanism, carboxylated microspheres are used for cross-linking an anti-IgE antibody, an IgE-allergen compound in a sensitization stage of a detection sample is combined and captured, interference of residual components of the sample is removed through multiple times of cleaning, the antibody and drug binding protein are digested by enzyme to dissociate drug components, and the immunogenicity of the IgE-allergen compound in the sensitization stage of the detection sample is improved. And the LC-MS is used for qualitatively detecting medicine components so as to achieve the purpose of detecting the medicine allergen.
Owner:CHINA UNIVERSITY OF POLITICAL SCIENCE AND LAW

Topical roflumilast formulation having antifungal properties

The present invention is directed to a method of treating a fungal infection comprising administering topically, to a subject in need thereof, an anti-fungal effective amount of roflumilast. Preferably, topically administered roflumilast is used to treat fungal infections, fungal growth of and / or hypersensitivity to the fungi Malassezia spp. Patients may also be suffering from seborrheic dermatitis, dandruff, dupilumab facial redness, Tinea versicolor, Pityriasis versicolor, Tinea circinata, Tinea pedis, Tinea unguium, Tinea manus, Tinea cruris, Tinea corporis, Tinea faciei, Tinea capitis, and / or Tinea incognito. Topically administered roflumilast is a quick and effective antifungal agent and presents a viable alternative to current antifungal treatments.
Owner:ARCUTIS BIOTHERAPEUTICS INC

Application of sulforaphane and / or sulforaphane clathrate compound in preparation of medicine for treating and / or relieving irritable bowel syndrome and visceral hypersensitivity and regulating intestinal motility or intestinal barrier

The invention relates to the technical field of medicines, and provides application of sulforaphane and / or a sulforaphane inclusion compound in preparation of medicines for treating and / or relieving irritable bowel syndrome and visceral hypersensitivity and regulating intestinal motility or intestinal barrier. The sulforaphane provided by the invention can effectively reduce visceral hypersensitivity, regulate intestinal motility and improve intestinal barrier in preparation of medicines for treating functional bowel diseases such as irritable bowel syndrome, especially in preparation of medicines for treating visceral hypersensitivity, abnormal intestinal motility and damaged intestinal barrier function, so that the sulforaphane can be used for treating functional bowel diseases such as irritable bowel syndrome and the like. The traditional Chinese medicine composition has the effect of relieving and treating the irritable bowel syndrome. According to the sulforaphane inclusion compound, the stability and bioavailability of the sulforaphane are further improved, the half-life period of the medicine is prolonged, the treatment effect is enhanced, and the potential of the sulforaphane in clinical application is expanded.
Owner:PIONEER HERB IND CO LTD

Purine ring-containing compound and use thereof

PCT designated stage expiredWO2025148955A1AntipyreticAnalgesicsMetabolitePurine
Provided are a compound for treating or preventing hypersensitivity or autoimmune inflammation-related diseases, and the use and a method for treating or preventing the hypersensitivity or autoimmune inflammation-related diseases in a subject. The compound is a compound of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, ester, acid, metabolite or prodrug thereof.
Owner:HEFEI INSTITUTE OF PHYSICAL SCIENCE CHINESE ACADEMY OF SCIENCES

TPPP3 interfering RNA and its application

The present invention discloses an interfering RNA of TPPP3 and its application, belonging to the field of biomedicine preparation technology. The present invention discloses the application of a preparation for inhibiting TPPP3 in the preparation of a drug for treating type I hypersensitivity reaction, the preparation comprising an siRNA that interferes with the expression of TPPP3, and the nucleotide sequence of the siRNA is as shown in SEQ ID NO: 5-6. The present invention knocks down the TPPP3 gene by RNAi technology, and finds that downregulating the expression of the TPPP3 gene can significantly inhibit IgE-mediated mast cell degranulation, and reduces the activity of upstream signal molecules of the FcεRI signaling pathway to regulate type I hypersensitivity reaction, providing an experimental basis and scientific basis for revealing the pathogenesis of type I hypersensitivity reaction and in-depth research on the role of TPPP3 in type I hypersensitivity reaction.
Owner:HEBEI UNIVERSITY +1

Application of dietary fiber inulin in preparation of medicine for preventing prediabetic peripheral neuropathy

The invention provides application of dietary fiber inulin in preparation of a medicine for preventing prediabetic peripheral neuropathy, and belongs to the technical field of medicines. The invention provides medicine application of dietary fiber inulin, experiments prove that the dietary fiber inulin can effectively improve hyperalgesia, hyperalgesia hypersensitivity reaction and sensory nerve action potential change of peripheral neuropathy mice in the early stage of diabetes mellitus, and meanwhile, can remarkably repair sciatic nerve myelin sheath and axonal lesions, so that the dietary fiber inulin can be used for treating diabetes mellitus. The traditional Chinese medicine composition has the effect of remarkably improving prediabetic peripheral neuropathy.
Owner:NINGXIA HUI AUTONOMOUS REGION PEOPLES HOSPITAL

Use of the hir4 gene and / or its encoded protein in modulating plant pathogen resistance

This invention belongs to the field of genetic engineering technology, specifically relating to the application of the AtHIR4 gene and / or its encoded protein in regulating plant pathogen resistance. The amino acid sequence of the protein encoded by the AtHIR4 gene described in this invention is shown in SEQ ID No. 1. This invention created transgenic Arabidopsis and rapeseed expressing hypersensitivity response-inducible protein 4 (AtHIR4). In the AtHIR4 transgenic Arabidopsis, the chitin-activated ROS burst and phosphorylation of MAPKs were significantly enhanced. Disease resistance test results showed that the AtHIR4 transgenic plants not only exhibited enhanced resistance to the necrotrophic pathogens *Sclerotinia sclerotiorum* and *Botrytis cinerea*, but also significantly increased resistance to the semi-vitrotrophic pathogen *Pseudomonas syringae*. The AtHIR4 transgenic rapeseed also showed significantly enhanced resistance to *Sclerotinia sclerotiorum* and *Botrytis cinerea*.
Owner:HUAZHONG AGRI UNIV

Antigens for detecting toxoplasma infection by monitoring cellular immunity

Antigens of Toxoplasma gondii that provide specific and strong delayed type hypersensitivity (DTH) immune response, or which stimulate IFN-γ secretion, are used for testing subjects for infection. Any skin testing format may be adapted for testing for the delayed type hypersensitivity, including a patch, a needle, or a prong. Presence of DTH indicates infection. Alternate methods of detecting a T cell response including monitoring IFN-γ secretion may be used.
Owner:WASHINGTON UNIV IN SAINT LOUIS

Use of a postbiotic-based composition for the treatment of skin diseases

The present invention refers to a composition including a fermented supernatant of Lactobacillus casei or paracasei species The species is characterized by having in its DNA genome at least one DNA sequence essentially identical to one of the sequences selected from the group consisting of: SEQ ID No 1 to 5, and proper diluents and / or carriers and / or excipients. The compositions can be used in the treatment and / or prevention of skin and / or dermatological diseases related to inflammation, allergic reactions, contact hypersensitivity reactions and intolerance, excessive sebaceous secretion, exfoliation or microbial dysbiosis, preferably of the epidermis.
Owner:POSTBIOTICA SRL